Guardant Health Q4 Revenues Up 64 Percent | GenomeWeb

Guardant Health Q4 Revenues Up 64 Percent

Mar 12, 2019

|

NEW YORK (GenomeWeb) – Guardant Health's stock surged in Wednesday morning trading after the company reported that its fourth quarter revenues rose 64 percent year over year, driven by a 98 percent increase in revenues from its precision oncology business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Concerns About Bias in Policies

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Reprogrammable DNA

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Lack of Diversity

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

This Week in Science

In Science this week: whole-genome sequencing of single sperm cells, and more.